| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |